Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1996-01-11
1998-05-26
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514357, 514447, 514472, 514331, 514399, 514352, 514542, 514600, 514607, 544160, 544334, 546232, 546312, 546334, 5483401, 560 13, 560302, 564 79, 564101, C07D21128, C07D23364, C07D26530, A61K 3138
Patent
active
057564981
ABSTRACT:
Sulfonylalkanoylamino hydroxyethylamino sulfonyl urea derivative compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease.
In accordance with the present invention, compounds of Formula (I) are disclosed ##STR1## wherein the substituents are as defined in the specification.
REFERENCES:
patent: H725 (1990-01-01), Gordon
patent: 4450164 (1984-05-01), Bristol et al.
patent: 4477441 (1984-10-01), Boger et al.
patent: 4514391 (1985-04-01), Gordon et al.
patent: 4548926 (1985-10-01), Matsueda et al.
patent: 4599198 (1986-07-01), Hoover
patent: 4616088 (1986-10-01), Ryono et al.
patent: 4668769 (1987-05-01), Hoover
patent: 4668770 (1987-05-01), Boger et al.
patent: 4757050 (1988-07-01), Natarajan et al.
patent: 4880938 (1989-11-01), Freidinger
patent: 4963530 (1990-10-01), Hemmi et al.
patent: 4977277 (1990-12-01), Rosenberg et al.
patent: 5340828 (1994-08-01), Graham et al.
patent: 5583132 (1996-12-01), Vazquez et al.
Roberts et al, "Rational Design of Peptide-based Proteinase Inhibitors, " Science, 248, 358 (1990). Month of publication not provided.
Erickson et al, "Design Activity and 2.8A Crystal Structure of a C.sub.2 Symmetric Inhibitor complexed to HIV-1 Protease," Science, 249, 527 (1990). Month of publication not provided.
Pearl et al, "Sequence specificity of retroviral proteases" Nature, 328, p. 482 (1987) month of publication not provided.
Martin, Drugs of the Future, 16(3), 210-212 (1991) month of publication not provided.
Meek et al., Letter To Nature, 343, 90-92 (1990) month of publication not provided.
McQuade et al, Science, 274, 454-456 (1990) month of publication not provided.
Rosenberg et al, J. Med. Chem., 30, 1224-1228 (1987) (publication month not provided).
Sham et al., Biochem. Biophys. Res. Comm., 211:159-165 (Jun. 1995).
Thaisrivongs, S., et al,. J. Med. Chem., 38:3624-3637 (Sep. 1995).
Sakural M., et al., Chem. Pharm. Bull., 42:523-540 (Mar. 1994).
Gilchrist, T.L. Aromatic Hetocyclic Chem., 2:370, 373, 375, 379 (1974).
Anderson, Design of Prodrugs, edited by Bungaard, H. (Elsevier, Amsterdam), p. 244 (1985).
Kurzer, F. Adv. Heterocyclic Chem., 5:119, 157, 159 (1965).
Reid et al., Adv. Heterocyclic Chem., 35:197, 254 (1984).
Katritzky, A.R., et al., Handbook of Heterocyclic Chemistry (Pergamon Press, Osford) pp. 148, 151, 167, 169, 173, 174, 317, 318 (1985).
Gilchrist, T.L. Aromatic Heteroaromatic Chem., 41:57, 68, 69 (1987).
Kurzer, F., Adv. Heterocyclic Chem., 32:358 (1982).
Gilchrist, T.L. Aromatic Heteroaromatic Chem., 4:360, 363, 367 (1976).
DeCrescenzo Gary A.
Getman Daniel P.
Mueller Richard A.
Sun Eric T.
Talley John J.
G.D. Searle & Co.
Shah Mukund J.
Wong King Lit
LandOfFree
Sulfonylalkanoylamino hydroxyethylamino sulfonyl urea derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sulfonylalkanoylamino hydroxyethylamino sulfonyl urea derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sulfonylalkanoylamino hydroxyethylamino sulfonyl urea derivative will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1960309